{"product_id":"in-silico-models-for-drug-sandhya-kortagere-9781627033411","title":"In Silico Models for Drug Discovery","description":"\u003cp\u003e1. Virtual Screening in Drug Design \u003c\/p\u003e\u003cp\u003eMarkus Lill\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e2. In Silico Systems Biology Approaches for the Identification of Antimicrobial Targets \u003c\/p\u003e\u003cp\u003eMalabika Sarker, Carolyn Talcott, and Amit K. Galande\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e3. Genome Comparisons as a Tool for Antimicrobial Target Discovery\u003c\/p\u003e\u003cp\u003eHong Sun, Hai-Feng Chen, and Runsheng Chen\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e4. In Silico Models for Drug Resistance \u003c\/p\u003e\u003cp\u003eSegun Fatumo, Marion Adebiyi, and Ezekiel Adebiyi\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e5. An In Silico Model for Interpreting Polypharmacological Relationships in Drug-Target Networks \u003c\/p\u003e\u003cp\u003eIchigaku Takigawa, Koji Tsuda, and Hiroshi Mamitsuka\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e6. On Exploring Structure-Activity Relationships \u003c\/p\u003e\u003cp\u003eRajarshi Guha\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e7. Molecular Dynamics Simulations in Drug Design \u003c\/p\u003e\u003cp\u003eJohn E. Kerrigan\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e8. Databases and In Silico Tools for Vaccine Design \u003c\/p\u003e\u003cp\u003eYongqun He and Zuoshuang Xiang \u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e9. In Silico Models for B-Cell Epitope Recognition and Signaling \u003c\/p\u003e\u003cp\u003eHifzur Rahman Ansari and Gajendra P.S. Raghava\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e10. The Collaborative Drug Discovery (CDD) Database \u003c\/p\u003e\u003cp\u003eSean Ekins and Barry A. Bunin\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e11. Recognition of Nontrivial Remote Homology Relationships Involving Proteins of Helicobacter pylori: Implications for Function Recognition \u003c\/p\u003e\u003cp\u003eNidhi Tyagi and Narayanaswamy Srinivasan\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e12. Identification of Novel Anthrax Toxin Countermeasures Using In Silico Methods \u003c\/p\u003e\u003cp\u003eTing-Lan Chiu, Kimberly M. Maize, and Elizabeth A. Amin\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e13. Rational Design of HIV-1 Entry Inhibitors \u003c\/p\u003e\u003cp\u003eAsim K. Debnath\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e14. Malarial Kinases: Novel Targets for In Silico Approaches to Drug Discovery\u003c\/p\u003e\u003cp\u003eKristen M. Bullard, Robert Kirk DeLisle, and Susan M. Keenan\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e15. Designing Novel Inhibitors of Trypanosoma brucei \u003c\/p\u003e\u003cp\u003eﾖzlem Demir and Rommie E. Amaro\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e16. Computational Models for Tuberculosis Drug Discovery \u003c\/p\u003e\u003cp\u003eSean Ekins and Joel S. Freundlich\u003c\/p\u003e\u003cp\u003eRajarshi Guha\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e7. Molecular Dynamics Simulations in Drug Design \u003c\/p\u003e\u003cp\u003eJohn E. Kerrigan\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e8. Databases and In Silico Tools for Vaccine Design \u003c\/p\u003e\u003cp\u003eYongqun He and Zuoshuang Xiang \u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e9. In Silico Models for B-Cell Epitope Recognition and Signaling \u003c\/p\u003e\u003cp\u003eHifzur Rahman Ansari and Gajendra P.S. Raghava\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e10. The Collaborative Drug Discovery (CDD) Database \u003c\/p\u003e\u003cp\u003eSean Ekins and Barry A. Bunin\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e11. Recognition of Nontrivial Remote Homology Relationships Involving Proteins of Helicobacter pylori: Implications for Function Recognition \u003c\/p\u003e\u003cp\u003eNidhi Tyagi and Narayanaswamy Srinivasan\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e12. Identification of Novel Anthrax Toxin Countermeasures Using In Silico Methods \u003c\/p\u003e\u003cp\u003eTing-Lan Chiu, Kimberly M. Maize, and Elizabeth A. Amin\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e13. Rational Design of HIV-1 Entry Inhibitors \u003c\/p\u003e\u003cp\u003eAsim K. Debnath\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e14. Malarial Kinases: Novel Targets for In Silico Approaches to Drug Discovery\u003c\/p\u003e\u003cp\u003eKristen M. Bullard, Robert Kirk DeLisle, and Susan M. Keenan\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e15. Designing Novel Inhibitors of Trypanosoma brucei \u003c\/p\u003e\u003cp\u003eﾖzlem Demir and Rommie E. Amaro\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e16. Computational Models for Tuberculosis Drug Discovery \u003c\/p\u003e\u003cp\u003eSean Ekins and Joel S. Freundlich\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eAuthor:\u003c\/b\u003e Sandhya Kortagere\u003cbr\u003e\u003cb\u003eISBN-10:\u003c\/b\u003e 1627033416\u003cbr\u003e\u003cb\u003eISBN-13:\u003c\/b\u003e 9781627033411\u003cbr\u003e\u003cb\u003ePublisher:\u003c\/b\u003e Humana\u003cbr\u003e\u003cb\u003eLanguage:\u003c\/b\u003e English\u003cbr\u003e\u003cb\u003ePublished:\u003c\/b\u003e 04\/09\/2013\u003cbr\u003e\u003cb\u003ePages:\u003c\/b\u003e 265\u003cbr\u003e\u003cb\u003eFormat:\u003c\/b\u003e Hardcover\u003cbr\u003e\u003cb\u003eWeight:\u003c\/b\u003e 1.65lbs\u003cbr\u003e\u003cb\u003eSize:\u003c\/b\u003e 10.10h x 7.20w x 0.80d","brand":"Sandhya Kortagere","offers":[{"title":"Hardcover","offer_id":44067885515007,"sku":"9781627033411","price":169.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/2982\/9887\/files\/img_12a3e3ed-6898-4c04-bf26-13848e7c444d.jpg?v=1685415838","url":"https:\/\/www.whiterainbookhouse.com\/products\/in-silico-models-for-drug-sandhya-kortagere-9781627033411","provider":"WR Book House","version":"1.0","type":"link"}